I4C 2.0: Immunotherapy for Cure
I4C 2.0: Immunotherapy for Cure
批准号:
10615238
负责人:
Dan H. Barouch
金额:
$467.0万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-08-16 至 2026-04-30
关键词:
AcademiaActive ImmunizationAgonistB-LymphocytesBindingClonal ExpansionCommunitiesCommunity NetworksDisease remissionEngineeringEnsureFeedbackFinancial SupportGoalsGovernmentHIV-1HumanImmuneImmune responseImmunologic SurveillanceImmunologicsImmunotherapyIndustryLogisticsMacaca mulattaMonkeysNatural Killer CellsPassive ImmunizationRegimenResearchResidual stateResourcesSIVSamplingT-LymphocyteTLR7 geneUnited States National Institutes of HealthVaccine TherapyViralViral reservoirViruschimeric antigen receptor T cellsclinical developmentcommunity engagementimmunoengineeringimprovedinnovationneutralizing antibodynovel strategiesoperationpreventprogramssimian human immunodeficiency virustherapeutic vaccinetimelinetranscriptomicsviral rebound
中文摘要
点击翻译按钮获取中文摘要
英文摘要
SUMMARY
The goals of I4C 2.0 are to advance our scientific understanding of the viral reservoir and to develop immunologic
strategies for HIV-1 remission and eradication by a highly collaborative and multifaceted research program
involving partnerships among academia, industry, government, and the community. Our overall hypothesis is
that multiple immunologic strategies will need to be explored and combined to achieve long-term, ART-
free virologic control or complete virus eradication, with the goal of selecting combination regimens to
advance into clinical development by the end of the proposed period of support. We propose three
Research Foci, a Management and Operations Section, and a Community Engagement Section.
Focus 1 (Mechanistic Basis of Reservoir Targeting and Viral Persistence)
Aim 1. To define a virologic, immunologic, and transcriptomic signature of viral persistence and rebound and to
determine how immunologic strategies target the viral reservoir in NHPs and humans
Aim 2. To define drivers of clonal expansion and persistence of the replication-competent viral reservoir in NHPs
and humans to enhance reservoir control and elimination
Focus 2 (Novel Strategies for Sustained Virus Remission)
Aim 1. To evaluate innovative immune engineering strategies that provide long-term T cell or Env-directed
immune control, including therapeutic vaccines, CAR-T cells, and engineered B cells
Aim 2. To combine approaches that augment humoral and cellular immune responses to achieve sustained
immunosurveillance and long-term ART-free virologic control
Focus 3 (Novel Strategies for Virus Eradication)
Aim 1. To evaluate innovative strategies for rapid elimination of the majority of the viral reservoir, including
improved LRAs combined with bNAbs, activated NK cells, and CAR-T cells
Aim 2. To combine the most effective approach to rapidly eliminate the majority of the viral reservoir with
sustained immunosurveillance to eliminate the residual viral reservoir
Management and Operations (MO) Section
Community Engagement (CE) Section
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1038/s41541-022-00477-x
发表时间:
2022-05-18
期刊:
NPJ VACCINES
影响因子:
9.2
作者:
[Ventura, John D., Nkolola, Joseph P., Chandrashekar, Abishek, Borducchi, Erica N., Liu, Jinyan, Mercado, Noe B., Hope, David L., Giffin, Victoria M., McMahan, Katherine, Geleziunas, Romas, Murry, Jeffrey P., Yang, Yunling, Lewis, Mark G., Pau, Maria G., Wegmann, Frank, Schuitemaker, Hanneke, Fray, Emily J., Kumar, Mithra R., Siliciano, Janet D., Siliciano, Robert F., Robb, Merlin L., Michael, Nelson L., Barouch, Dan H.]
通讯作者:
Barouch, Dan H.
NHP Core
-
批准号:10724223
-
项目类别:
-
资助金额:$28.54万
-
财政年份:2023
-
负责人:Dan H. Barouch
-
依托单位:
Multi-Omics Analysis of Broadly Neutralizing Antibodies and Therapeutic Vaccination
-
批准号:10724219
-
项目类别:
-
资助金额:$141.27万
-
财政年份:2023
-
负责人:Dan H. Barouch
-
依托单位:
Administrative Core
-
批准号:10724220
-
项目类别:
-
资助金额:$15.5万
-
财政年份:2023
-
负责人:Dan H. Barouch
-
依托单位:
Multi-Omics Correlates of Broadly Neutralizing Antibody Efficacy
-
批准号:10724224
-
项目类别:
-
资助金额:$23.25万
-
财政年份:2023
-
负责人:Dan H. Barouch
-
依托单位:
CoVPN LOC Cross-Protocol Infrastructure Supplement for GY15 and GY16
-
批准号:10571201
-
项目类别:
-
资助金额:$532.4万
-
财政年份:2022
-
负责人:Dan H. Barouch
-
依托单位:
Project 2: Analysis of Reservoir Dynamics in SIV-Infected Rhesus Macaques
-
批准号:10599365
-
项目类别:
-
资助金额:$69.64万
-
财政年份:2022
-
负责人:Dan H. Barouch
-
依托单位:
Project 2: Analysis of Reservoir Dynamics in SIV-Infected Rhesus Macaques
-
批准号:10459662
-
项目类别:
-
资助金额:$40.12万
-
财政年份:2022
-
负责人:Dan H. Barouch
-
依托单位:
HIV Vaccines Clinical Trials Network Leadership and Operations Center
-
批准号:10311601
-
项目类别:
-
资助金额:$4312.46万
-
财政年份:2021
-
负责人:Dan H. Barouch
-
依托单位:
I4C 2.0: Immunotherapy for Cure
-
批准号:10469460
-
项目类别:
-
资助金额:$467.78万
-
财政年份:2021
-
负责人:Dan H. Barouch
-
依托单位:
I4C 2.0: Immunotherapy for Cure
-
批准号:10311894
-
项目类别:
-
资助金额:$490.47万
-
财政年份:2021
-
负责人:Dan H. Barouch
-
依托单位:
CoVPN 3005 - Efficacy, Immunogenicity, and Safety of SARS-CoV-2 Recombinant Protein Vaccine with Adjuvant in Adults 18 Years of Age and Older
-
批准号:10415762
-
项目类别:
-
资助金额:$6142.91万
-
财政年份:2021
-
负责人:Dan H. Barouch
-
依托单位:
Single-Cell Analysis of the HIV/SIV Reservoir
-
批准号:9892744
-
项目类别:
-
资助金额:$83.99万
-
财政年份:2020
-
负责人:Dan H. Barouch
-
依托单位:
Single-Cell Analysis of the HIV/SIV Reservoir
-
批准号:10406264
-
项目类别:
-
资助金额:$82.11万
-
财政年份:2020
-
负责人:Dan H. Barouch
-
依托单位:
Single-Cell Analysis of the HIV/SIV Reservoir
-
批准号:10188413
-
项目类别:
-
资助金额:$82.11万
-
财政年份:2020
-
负责人:Dan H. Barouch
-
依托单位:
Ad26 Based Therapeutic Vaccines for HIV
-
批准号:10399642
-
项目类别:
-
资助金额:$150.39万
-
财政年份:2020
-
负责人:Dan H. Barouch
-
依托单位:
Single-Cell Analysis of the HIV/SIV Reservoir
-
批准号:10840033
-
项目类别:
-
资助金额:$43.23万
-
财政年份:2020
-
负责人:Dan H. Barouch
-
依托单位:
Immunologic Signatures of SARS-CoV-2 Vaccination and Disease
-
批准号:10855012
-
项目类别:
-
资助金额:$89.77万
-
财政年份:2020
-
负责人:Dan H. Barouch
-
依托单位:
Single-Cell Analysis of the HIV/SIV Reservoir
-
批准号:10634684
-
项目类别:
-
资助金额:$82.11万
-
财政年份:2020
-
负责人:Dan H. Barouch
-
依托单位:
Ad26 Based Therapeutic Vaccines for HIV
-
批准号:10163123
-
项目类别:
-
资助金额:$150.43万
-
财政年份:2020
-
负责人:Dan H. Barouch
-
依托单位:
Immunologic Signatures of SARS-CoV-2 Vaccination and Disease
-
批准号:10688351
-
项目类别:
-
资助金额:$72.54万
-
财政年份:2020
-
负责人:Dan H. Barouch
-
依托单位:
海外基金